The State of Texas Attorney General Sues Acetaminophen Makers Concerning Autism Allegations

Courtroom Proceedings
Ken Paxton, a Trump ally who is running for the United States Senate, alleged pharmaceutical manufacturers of concealing the risks of acetaminophen

Texas Attorney General Ken Paxton is filing a lawsuit against the producers of Tylenol, asserting the corporations concealed alleged dangers that the drug created to children's brain development.

This legal action comes thirty days after President Donald Trump publicized an unproven link between taking acetaminophen - alternatively called paracetamol - throughout gestation and autism spectrum disorder in children.

The attorney general is filing suit against J&J, which formerly manufactured the drug, the exclusive pain medication suggested for pregnant women, and the current manufacturer, which now manufacturers it.

In a official comment, he said they "deceived the public by making money from suffering and marketing drugs regardless of the dangers."

The manufacturer says there is insufficient reliable data tying acetaminophen to autism.

"These manufacturers misled for generations, intentionally threatening numerous people to increase profits," Paxton, from the Republican party, said.

The company said in a statement that it was "deeply concerned by the perpetuation of misinformation on the security of acetaminophen and the potential impact that could have on the health of US mothers and children."

On its website, the company also stated it had "regularly reviewed the relevant science and there is insufficient valid information that shows a verified association between using acetaminophen and autism."

Associations acting on behalf of doctors and health professionals agree.

ACOG has stated acetaminophen - the primary component in Tylenol - is a restricted selection for women during pregnancy to treat discomfort and fever, which can present serious health risks if ignored.

"In over twenty years of investigation on the use of paracetamol in gestation, no reliable research has successfully concluded that the consumption of acetaminophen in any stage of pregnancy leads to neurological conditions in offspring," the association commented.

This legal action cites current declarations from the Trump administration in asserting the drug is reportedly hazardous.

Last month, the former president raised alarms from public health officials when he told women during pregnancy to "struggle intensely" not to take acetaminophen when unwell.

The FDA then released a statement that doctors should contemplate reducing the consumption of Tylenol, while also declaring that "a causal relationship" between the medication and autism spectrum disorder in minors has not been proven.

Health Secretary RFK Jr, who oversees the FDA, had pledged in spring to undertake "a massive testing and research effort" that would establish the cause of autism spectrum disorder in a matter of months.

But experts advised that identifying a sole reason of autism - thought by researchers to be the result of a complex mix of inherited and environmental factors - would be difficult.

Autism is a category of permanent neurological difference and condition that impacts how persons perceive and relate to the world, and is recognized using physician assessments.

In his court filing, Paxton - a Trump ally who is seeking the Senate - asserts Kenvue and Johnson & Johnson "deliberately disregarded and attempted to silence the evidence" around paracetamol and autism spectrum disorder.

The case seeks to make the companies "eliminate any marketing or advertising" that states Tylenol is safe for expectant mothers.

This legal action mirrors the complaints of a group of mothers and fathers of children with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the manufacturers of Tylenol in two years ago.

Judicial authorities threw out the legal action, saying research from the parents' expert witnesses was inconclusive.

Andrew Melendez
Andrew Melendez

Tech enthusiast and AI researcher with a passion for simplifying complex tools for everyday use.

March 2026 Blog Roll

February 2026 Blog Roll

December 2025 Blog Roll

Popular Post